Lifecare ASA — Investor Presentation 2021

Nov 8, 2021

Presentation of Forget Diabetes project

Presentation of Forget Diabetes project

Bergen, Norway 8 November 2021

Please find enclosed the presentation held by Lifecare AS’ CSO Prof. Andreas Pfützner at the 20th annual Diabetes Tech Meeting 6 November 2021. Topic of the presentation was the EU funded project Forget Diabetes: a novel automated insulin delivery system, of which Lifecare in cooperation with 6 academic partners cross Europe aim to develop an artificial pancreas where the sensing system is based on the Sencell technology.

This is Lifecare

Lifecare is a Bergen-based technology company developing a miniaturized implantable long-term sensor for correct and continuous monitoring of blood sugar in people with diabetes. The Company's patented technology also has the potential for use in various biomarkers. Lifecare AS is listed on Euronext Growth (LIFE).

Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

This stock exchange announcement was published by Kine Hereid, Investor Relations at Lifecare AS, on 08.11.2021 at 08.30 CET.